A paper recently published by Second Nature found that 44% of people on our medication-supported weight-loss programme reported feeling more tired than usual after 4 weeks on a similar drug to Mounjaro called Wegovy
For many, its become a revolutionary tool in achieving long-term weight loss goals
Whether the same magnitude of inflammation reduction translates to lupus patients with different baseline immune profiles remains to be established
Ferrannini, E., Balkau, B., Coppack, S
But I also want people to see that every garment in Changing the Thread Collection is a story of resilience
Most weight loss research focuses on GLP-1 monotherapy or investigates newer dual-agonist medications like tirzepatide, which activates both GLP-1 and GIP receptors for enhanced metabolic effects